Search - tctmd.com

Displaying 881 - 900 of 1152

Sort: Relevancy | Date

News Industry News

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

November 04, 2012

News Industry News

Vascular Solutions Launches the R-Band Radial Compression Device

October 31, 2012

News Industry News

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

October 31, 2012

News Industry News

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

October 29, 2012

News Industry News

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

October 29, 2012

News Industry News

Gore Reacts to RESPECT Trial Results

October 26, 2012

News Industry News

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

October 25, 2012

News Industry News

NeoChord’s mitral valve repair device to be featured at 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS)

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

October 25, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Industry News

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

October 24, 2012

News Industry News

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

News Industry News

Medtronic Stent Successfully Treats Long Lesions and Small Vessels, Two Characteristics Typical of Patients with Diabetes, in Multiple Studies

October 23, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

News Industry News

STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing® Stent

October 22, 2012

Advertisement

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

Vascular Solutions Launches the R-Band Radial Compression Device

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

Gore Reacts to RESPECT Trial Results

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

NeoChord’s mitral valve repair device to be featured at 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS)

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Medtronic Stent Successfully Treats Long Lesions and Small Vessels, Two Characteristics Typical of Patients with Diabetes, in Multiple Studies

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing® Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content